Viewing Study NCT01284166


Ignite Creation Date: 2025-12-24 @ 4:27 PM
Ignite Modification Date: 2025-12-29 @ 8:25 AM
Study NCT ID: NCT01284166
Status: WITHDRAWN
Last Update Posted: 2013-07-18
First Post: 2011-01-25
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Efficacy of Triple Combination Therapy With Dorzolamide Hydrochloride / Brimonidine Tartrate / Timolol Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension
Sponsor: Allergan
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2013-07
Start Date Type: None
Primary Completion Date: 2014-05
Primary Completion Date Type: ESTIMATED
Completion Date: 2014-05
Completion Date Type: ESTIMATED
First Submit Date: 2011-01-25
First Submit QC Date: None
Study First Post Date: 2011-01-26
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2013-07-17
Last Update Post Date: 2013-07-18
Last Update Post Date Type: ESTIMATED